Rare Haematological Disorders

Rare haematological disorders are a diverse group of uncommon conditions that affect the blood, bone marrow, lymphatic system, or blood-clotting mechanisms. These disorders may be inherited or acquired and often require specialised medical care due to their complexity. Although individually uncommon, collectively they affect many people worldwide and can significantly impact quality of life if left untreated.

Examples include aplastic anaemia, paroxysmal nocturnal haemoglobinuria (PNH), congenital bone marrow failure syndromes, thrombotic thrombocytopenic purpura (TTP), hereditary spherocytosis, and rare clotting factor deficiencies. Symptoms vary depending on the specific disorder but commonly include persistent fatigue, recurrent infections, unusual bleeding or bruising, enlarged spleen, blood clots, and chronic anaemia.

Diagnosis often requires a combination of complete blood counts, peripheral blood smear examination, bone marrow biopsy, genetic testing, immunological studies, and specialised laboratory investigations. Because many rare blood disorders share similar symptoms with more common illnesses, accurate diagnosis may take time and involve multidisciplinary specialists.

Treatment depends on the underlying condition and may include blood transfusions, immunosuppressive therapy, targeted medications, enzyme replacement, iron chelation, stem cell transplantation, or supportive care. Regular follow-up is essential to monitor disease progression and treatment response. Advances in molecular diagnostics, precision medicine, and novel therapies continue to improve survival rates, symptom control, and long-term outcomes for patients with rare haematological disorders.